Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q2 2020 · 10-Q
Revenue$238.07M$238.07M−0.5% vs Q2 2019 Net Income$33.25M$33.25M+7.8% vs Q2 2019 EPS Diluted$0.65$0.65+10.2% vs Q2 2019 Gross Profit$136,751,000−0.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$50,223,000+27.9% Free Cash Flowderived$46,357,000+26.5% Margins · derivedGross margin57.4%+0.0 pt vs Q2 2019
Operating margin29.1%−0.5 pt vs Q2 2019
Net margin14.0%+1.1 pt vs Q2 2019
ended Sep 30, 2019 · filed Oct 31, 2019 · 31 d after period end